Mitomycin C

CAS No. 50-07-7

Mitomycin C( Ametycine )

Catalog No. M14682 CAS No. 50-07-7

Mitomycin C (Ametycine) is a chemotherapeutic antibiotic that acts as a double-stranded DNA alkylating agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Mitomycin C
  • Note
    Research use only, not for human use.
  • Brief Description
    Mitomycin C (Ametycine) is a chemotherapeutic antibiotic that acts as a double-stranded DNA alkylating agent.
  • Description
    Mitomycin C (Ametycine) is a chemotherapeutic antibiotic that acts as a double-stranded DNA alkylating agent.(In Vitro):The HCT116 (p53-/-) cells are minimally sensitive to either Mitomycin C (Ametycine) or TRAIL alone. However, surprisingly, combination treatment with MMC and TRAIL decreases cell viability significantly. Although Mitomycin C and TRAIL alone are moderately effective, Mitomycin C substantially enhances the effect of TRAIL on suppression of the cell proliferation. Mitomycin C and TRAIL treatment alone induces 9.5% and 35.0% apoptosis, respectively. However, combination treatment with Mitomycin C and TRAIL enhances apoptosis to 66.6%.Mitomycin C is a cytotoxic chemotherapeutic agent that causes DNA damage in the form of DNA cross-links as well as a variety of DNA monoadducts and is known to induce p53.(In Vivo):Mice bearing xenografted HCT116 (p53-/-) colon tumors and HT-29 colon tumors are treated with Mitomycin C (Ametycine; i.p., 1 mg/kg) and TRAIL (i.v., 100 μg) every other day. Animals are treated with 10 consecutive cycles of the combination therapy regimen. The combination therapy suppresses tumor growth significantly and does not impact the weight of the mice, indicating that the therapeutic combination of Mitomycin C and TRAIL is well-tolerated and has anti-tumor activity in vivo.Intravesical Mitomycin C instillations has an effect on body weight. After 3 consecutive weekly instillations of 1 mg/mL Mitomycin C there is almost no weight gain, whereas rats in the other 3 groups has a statistically significant weight gain compared with MMC treated rats.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Ametycine
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA Alkylator
  • Recptor
    DNAsynthesis
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    50-07-7
  • Formula Weight
    334.3
  • Molecular Formula
    C15H18N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 30 mg/mL
  • SMILES
    NC(OC[C@H]1[C@]([C@](N2)([H])[C@]2([H])C3)(OC)N3C4=C1C(C(N)=C(C)C4=O)=O)=O
  • Chemical Name
    Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Umemoto N, et al. J Appl Biochem. 1984 Oct-Dec;6(5-6):297-307. 2. Barlogie B, et al. Cancer Res. 1980 Jun;40(6):1973-80. 3. Marshall RS, et al. Cancer Res. 1988 Oct 15;48(20):5655-9. 4. Sklarin NT, et al. Cancer Res. 1988 Jan 1;48(1):64-7.
molnova catalog
related products
  • Crystal Violet

    Crystal violet is a triarylmethane dye.

  • Glufosfamide

    A conjugate of glucose and active alkylating moiety of ifosfamide with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters.

  • Busulfan

    Busulfan is a bifunctional alkylating agent.